期刊文献+

腹腔镜改良腹膜后淋巴结清扫术治疗临床Ⅰ期睾丸非精原细胞瘤的疗效评价:附7例报告 被引量:4

Efficacy of modified laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor:Report of 7 cases
原文传递
导出
摘要 目的探讨经腹途径腹腔镜改良腹膜后淋巴结清扫术治疗临床Ⅰ期睾丸非精原细胞瘤的疗效。方法回顾性分析2008年7月至2010年6月在中山大学肿瘤防治中心收治的7例临床Ⅰ期睾丸非精原细胞瘤的患者,均于睾丸癌根治术后接受腹腔镜改良腹膜后淋巴结清扫术。结果 7例患者腹腔镜改良腹膜后淋巴结清扫术的平均手术时间302.9±88.3min(190~410min),术中平均出血量为111.4±83.2m(l30~200ml),送病理检查的淋巴结平均22.8±11.1枚(9~36枚),无手术并发症发生。术后平均住院时间6d。术后病理分期均为Ⅰ期。所有患者随访2~24个月,平均14.1±8.2个月,均无肿瘤复发或转移,血AFP和β-HCG亦无异常升高,所有患者都维持正常射精功能。结论腹腔镜改良腹膜后淋巴结清扫术能够有效地治疗临床Ⅰ期睾丸非精原细胞瘤,同时具有并发症少和切口美观、创伤小的优势。 Ojective To evaluate the efficacy of modified laparoscopic retroperitoneal lymph node dissection(L-RPLND) for clinical stage I non-seminomatous germ cell tumors(NSGCTs).Methods Clinical data of 7 cases with clinical stage I NSGCTs from July 2008 to June 2010 in Sun Yat-sen University Cancer Center were retrospectively analyzed.All cases received modified L-RPLND after radical orchidectomy.Results The mean operating time of modified L-RPLND was 302.9±88.3 min(190-410) and the mean blood loss was 111.4±83.2 ml(30-200).The mean number of dissected lymph nodes sent for pathological examination was 22.8±11.1(9-36).There were no intra-operation and post-operation complications.The mean hospital stay time after operating was 6 days.Pathological stage(PS) I disease was found in all 7cases.The mean follow-up time was 14.1±8.2 months(2-24).All patients achieved tumor-free survival,without elevation of blood alpha-fetal protein(AFP) or human chorionic gonadotropin(HCG).All the patients achieved antegrade ejaculation.Conclusion Modified L-RPLND achieves satisfactory outcomes in clinical stage I NSGCTs with few complication.
出处 《中华腔镜泌尿外科杂志(电子版)》 2011年第2期4-7,共4页 Chinese Journal of Endourology(Electronic Edition)
基金 广东省自然科学基金(7301094)
关键词 睾丸 非精原细胞瘤 腹腔镜 腹膜后淋巴结清扫 Testicle Nonseminatous germ cell tumors Laparoscopy Retroperitoneal lymph node dissection
  • 相关文献

参考文献14

  • 1刘卓炜,周芳坚,韩辉,秦自科,余绍龙,李永红,叶云林,滕小玉.睾丸非精原细胞瘤改良腹膜后淋巴结清扫术的疗效观察[J].癌症,2008,27(12):1302-1306. 被引量:4
  • 2Sonneveld DJ, Koops HS, Sleijfer DT, et al. Surgery versus surveil- lance in stage I non-seminoma testicular cancer. Semin Surg Oncol. 1999, 17(4): 230-239.
  • 3Heidenreich A, Albers P, Hartmann M, et al. Complications of pri- mary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol, 2003, 169(5):1710-1714.
  • 4Mykletun A, Dahl AA, Haaland CF, et al. Side effects and cancer- related stress determine quality of life in long-term survivors of tes- ticular cancer. J Clin Oncol, 2005, 23(13): 3061-3068.
  • 5Huddart RA, Birtle AJ. Recent advances in the treatment of testicu- lar cancer. Expert Rev Anticancer Ther, 2005, 5(1): 123-138.
  • 6Steiner H, Peschel R, Bartsch G. Laparoscopic retroperitoneal lymph node dissection: current concepts and limitations. BJU Int, 2009, 104(9): 1376-1380.
  • 7Williams SB, McDermott DW, Dock W, et al. Retroperitoneal lymph node dissection in patients with high risk testicular cancer. J Urol, 2009, 181(5): 2097-2101.
  • 8Sheinfeld J. The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controver- sies. Semin Urol Oncol, 2002, 20(4): 262-271.
  • 9Rassweiler JJ, Scheitlin W, Heidenreich A, et al. Laparoscopicretroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Eur Urol, 2008, 54(5): 1004-1015.
  • 10Benway BM, Diaz DL, Katz MD, et al. Open versus laparoscopic retroperitoneal lymph node dissection: assessing adequacy of dissec- tion in a porcine model. J Endourol, 2009, 23(3): 485-488.

二级参考文献27

  • 1叶定伟,方银忠,戴波,顾卫列,刘守业.睾丸肿瘤腹膜后淋巴结清扫术39例报告[J].中华泌尿外科杂志,2005,26(4):283-285. 被引量:10
  • 2刘卓炜,丘少鹏,周芳坚,梅骅,秦自科,韩辉.保留神经腹膜后淋巴结清除术治疗睾丸肿瘤[J].中华泌尿外科杂志,2005,26(7):491-493. 被引量:7
  • 3Donohue J P, Foster R S. Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques[J]. Urol Clin North Am, 1998,25(3): 461-468.
  • 4International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers [J]. J Clin Oncol, 1997; 15(2) :594-603.
  • 5Huddart R A, Birtle A J. Recent advances in the treatment of testicular cancer[ J ]. Expert Rev Anticancer Ther, 2005,5 ( 1 ) : 123-138.
  • 6Hilton S, Herr H W, Teitcher J B, et al. CT detection of retroperitoneal lymph node metastases in patients with clinical stage Ⅰ testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. [J]. AJR Am J Roentgenol, 1997,169(2) : 521-525.
  • 7Cremerius U, Wildberger J E, Borchers H, et al. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testieular cancer?-Results of a study in 50 patients[J]. Urology, 1999,54(5):900-904.
  • 8Nicolai N, Mieeli R, Artusi R, et al. A simple model for predicting nodal metastasis in patients with clinical stage Ⅰ nonseminomatous germ cell testicular tumors undergoing retropefitoneal lymph node dissection only[J]. J Urol, 2004, 171(1): 172-176
  • 9Heidenreich A, Albers P, Hartmann M, et al. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group [J]. J Urol, 2003,169(5) : 1710-1714.
  • 10Mykletun A, Dahl A A, Haaland C F, et al. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer[J]. J Clin Oncol, 2005,23 (13) : 3061-3068.

共引文献5

同被引文献38

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部